Singapore markets close in 1 hour 59 minutes
Straits Times Index
3,279.70 -13.43 (-0.41%) Nikkei
37,628.48 -831.60 (-2.16%) Hang Seng
17,267.95 +66.68 (+0.39%) FTSE 100
8,040.38 -4.43 (-0.06%) Bitcoin USD
64,271.38 -2,490.60 (-3.73%) CMC Crypto 200
1,389.18 +6.60 (+0.48%)
Verve Therapeutics, Inc. (VERV)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 550.21M |
| Enterprise value | 1.17M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 35.91 |
| Price/book (mrq) | 0.92 |
| Enterprise value/revenue | 0.10 |
| Enterprise value/EBITDA | -0.01 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.70 |
| 52-week change 3 | -58.20% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 21.42 |
| 52-week low 3 | 6.42 |
| 50-day moving average 3 | 11.89 |
| 200-day moving average 3 | 13.26 |
Share statistics
| Avg vol (3-month) 3 | 1.3M |
| Avg vol (10-day) 3 | 1.07M |
| Shares outstanding 5 | 83.62M |
| Implied shares outstanding 6 | 83.62M |
| Float 8 | 66.88M |
| % held by insiders 1 | 7.65% |
| % held by institutions 1 | 87.15% |
| Shares short (28 Mar 2024) 4 | 15.36M |
| Short ratio (28 Mar 2024) 4 | 12.95 |
| Short % of float (28 Mar 2024) 4 | 23.71% |
| Short % of shares outstanding (28 Mar 2024) 4 | 18.37% |
| Shares short (prior month 29 Feb 2024) 4 | 12.52M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,048.76% |
Management effectiveness
| Return on assets (ttm) | -19.48% |
| Return on equity (ttm) | -34.78% |
Income statement
| Revenue (ttm) | 11.76M |
| Revenue per share (ttm) | 0.18 |
| Quarterly revenue growth (yoy) | 408.30% |
| Gross profit (ttm) | N/A |
| EBITDA | -217.67M |
| Net income avi to common (ttm) | -200.07M |
| Diluted EPS (ttm) | -3.12 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 623.95M |
| Total cash per share (mrq) | 7.46 |
| Total debt (mrq) | 74.91M |
| Total debt/equity (mrq) | 12.49% |
| Current ratio (mrq) | 17.24 |
| Book value per share (mrq) | 7.31 |
Cash flow statement
| Operating cash flow (ttm) | -149.55M |
| Levered free cash flow (ttm) | -110.19M |
© 2024 Yahoo. All rights reserved.